Related Experiment Video
Updated: Jun 8, 2026

Mapping the Structure-Function Relationships of Disordered Oncogenic Transcription Factors Using Transcriptomic Analysis
Published on: June 27, 2020
FOXO1 is a direct target of EWS-Fli1 oncogenic fusion protein in Ewing's sarcoma cells
Liu Yang1, Hsien-Ming Hu, Anna Zielinska-Kwiatkowska
1Department of Orthopedics, University of Washington, Seattle, WA 98195, United States. lyang@u.washington.edu
Abstract:
Ewing's family tumors are characterized by a specific t(11;22) chromosomal translocation that results in the formation of EWS-Fli1 oncogenic fusion protein. To investigate the effects of EWS-Fli1 on gene expression, we carried out DNA microarray analysis after specific knockdown of EWS-Fli1 through transfection of synthetic siRNAs. EWS-Fli1 knockdown increased expression of genes such as DKK1 and p57 that are known to be repressed by EWS-Fli1 fusion protein. Among other potential EWS-Fli1 targets identified by our microarray analysis, we have focused on the FOXO1 gene since it encodes a potential tumor suppressor and has not been previously reported in Ewing's cells. To better understand how EWS-Fli1 affects FOXO1 expression, we have established a doxycycline-inducible siRNA system to achieve stable and reversible knockdown of EWS-Fli1 in Ewing's sarcoma cells. Here we show that FOXO1 expression in Ewing's cells has an inverse relationship with EWS-Fli1 protein level, and FOXO1 promoter activity is increased after doxycycline-induced EWS-Fli1 knockdown. In addition, we have found that direct binding of EWS-Fli1 to FOXO1 promoter is attenuated after doxycycline-induced siRNA knockdown of the fusion protein. Together, these results suggest that suppression of FOXO1 function by EWS-Fli1 fusion protein may contribute to cellular transformation in Ewing's family tumors.
Insights
Ewing's sarcoma cells have an inverse relationship between EWS-Fli1 oncogenic protein and FOXO1 tumor suppressor expression. Suppressing EWS-Fli1 increases FOXO1, suggesting its role in Ewing's family tumors.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Ewing's family of tumors (EFTs) are aggressive bone and soft tissue cancers.
- A hallmark of EFTs is the t(11;22) chromosomal translocation, creating the oncogenic EWS-Fli1 fusion protein.
- The precise mechanisms by which EWS-Fli1 drives tumorigenesis are not fully elucidated.
Purpose of the Study:
- To investigate the impact of EWS-Fli1 on gene expression in EFTs.
- To identify novel targets of EWS-Fli1, focusing on the tumor suppressor FOXO1.
- To characterize the regulatory relationship between EWS-Fli1 and FOXO1 in EFTs.
Main Methods:
- DNA microarray analysis was performed following siRNA-mediated knockdown of EWS-Fli1.
- A doxycycline-inducible siRNA system was established for stable and reversible EWS-Fli1 knockdown in EFT cells.
- FOXO1 expression, promoter activity, and EWS-Fli1 binding to the FOXO1 promoter were assessed.
Main Results:
- EWS-Fli1 knockdown led to increased expression of known repressed genes like DKK1 and p57.
- FOXO1 expression and promoter activity were inversely correlated with EWS-Fli1 protein levels.
- EWS-Fli1 binding to the FOXO1 promoter decreased upon EWS-Fli1 knockdown.
Conclusions:
- EWS-Fli1 directly suppresses FOXO1 expression in Ewing's sarcoma cells.
- The EWS-Fli1-mediated repression of FOXO1 may contribute to the cellular transformation observed in EFTs.
- Targeting the EWS-Fli1/FOXO1 axis presents a potential therapeutic strategy for Ewing's family tumors.
Related Concept Videos
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal
Canonical Wnt Signaling Pathway
Canonical Wnt Signaling Pathway
Regulation of Angiogenesis and Blood Supply
Induced Pluripotent Stem Cells
Somatic cells are...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...

